This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignees: Oregon Health & Science University, Research Development Foundation. Active years: 2014-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Portland, OR (US) (2014)
- Beaverton, OR (US) (2017)
Company Filing History:
2 out of 527 
2 out of 299 Years Active: 2014-2017
Title: Anna Dye: Inventor in Biomedical Research
Introduction
Anna Dye is an inventor associated with Beaverton, Oregon. Her patent work concerns RTEF-1 variants and their potential applications in regulating cellular processes and treating disease. She is credited with 2 patents.
Latest Patents
“RTEF-1 variants and uses thereof” describes modified RTEF-1 polypeptides containing one or more internal deletions that reduce VEGF promoter activity. The disclosure also covers nucleic acids encoding these variants and pharmaceutical compositions containing the polypeptides or nucleic acids.
The patent describes potential uses that include inducing cell contact inhibition, regulating organ size, and reducing intracellular YAP activity. It also discusses using the compositions to treat hyperproliferative diseases, including cancer.
Career Highlights
Dye’s listed organizational affiliations include the Research Development Foundation and Oregon Health & Science University. Her patent work reflects an emphasis on biomedical research and therapeutic applications.
Collaborations
Her listed coworkers include Binoy Appukuttan and Trevor McFarland.
Conclusion
Anna Dye’s patent portfolio focuses on RTEF-1 variants and their proposed roles in cellular regulation and potential disease treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile